A Prospective, Multicenter, Single-arm, Phase IV Study to Assess the Safety and Effectiveness of a Fixed-Dose Combination of Pregabalin Prolonged Release and Etoricoxib in Patients with Chronic Low Back Pain with a Neuropathic Component - Top-Institutions - MDSpire

A Prospective, Multicenter, Single-arm, Phase IV Study to Assess the Safety and Effectiveness of a Fixed-Dose Combination of Pregabalin Prolonged Release and Etoricoxib in Patients with Chronic Low Back Pain with a Neuropathic Component

  • By

  • Sandesh Sahebrao Patil

  • Brijesh Jerambhai Patel

  • Bhavsar Neel Mahendrabhai

  • C. L. Nawal

  • B. Valya

  • K. Sanjeev Kumar

  • Pandurang Wattamwar

  • Rana Kaushikkumar Ramanlal

  • Swagat Shah

  • Mandodari Rajurkar

  • Supriya Sonowal

  • Dipak Patil

  • Pravin Ghadge

  • Suyog Mehta

  • March 12, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Pain Management
    • Neurology
    • Anesthesiology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Pain Medicine
    • Rehabilitation Medicine

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Pain Management
    • Neurology
    • Orthopedics

  • #4

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Neurology
    • Pain Medicine
    • Pharmacology

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Pain Medicine
    • Neurology
    • Rehabilitation

Original Source(s)

A Prospective, Multicenter, Single-arm, Phase IV Study to Assess the Safety and Effectiveness of a Fixed-Dose Combination of Pregabalin Prolonged Release and Etoricoxib in Patients with Chronic Low Back Pain with a Neuropathic Component

  • by Sandesh Sahebrao Patil, Brijesh Jerambhai Patel, Bhavsar Neel Mahendrabhai, C. L. Nawal, B. Valya, K. Sanjeev Kumar, Pandurang Wattamwar, Rana Kaushikkumar Ramanlal, Swagat Shah, Mandodari Rajurkar, Supriya Sonowal, Dipak Patil, Pravin Ghadge, Suyog Mehta

  • March 12, 2026

Related Content

Checking in on RFK Jr.’s promises, one year later

An Overview of Opioid-Free Anesthesia: Evaluating Effectiveness, Safety, and Implementation Barriers

Fentanyl Is Not a WMD